Related Experiment Video
Updated: Jun 8, 2026

Assay to Measure Nucleocytoplasmic Transport in Real Time within Motor Neuron-like NSC-34 Cells
Published on: May 16, 2017
A genetic defect in exportin-5 traps precursor microRNAs in the nucleus of cancer cells
Sonia A Melo1, Catia Moutinho, Santiago Ropero
1Bellvitge Biomedical Research Institute, Barcelona, Catalonia, Spain.
Abstract:
The global impairment of mature microRNAs (miRNAs) is emerging as a common feature of human tumors. One interesting scenario is that defects in the nuclear export of precursor miRNAs (pre-miRNAs) might occur in transformed cells. Exportin 5 (XPO5) mediates pre-miRNA nuclear export and herein we demonstrate the presence of XPO5-inactivating mutations in a subset of human tumors with microsatellite instability. The XPO5 genetic defect traps pre-miRNAs in the nucleus, reduces miRNA processing, and diminishes miRNA-target inhibition. The XPO5 mutant form lacks a C-terminal region that contributes to the formation of the pre-miRNA/XPO5/Ran-GTP ternary complex and pre-miRNAs accumulate in the nucleus. Most importantly, the restoration of XPO5 functions reverses the impaired export of pre-miRNAs and has tumor-suppressor features.
Insights
Defects in Exportin 5 (XPO5) function, crucial for precursor microRNA (pre-miRNA) export, are found in some human tumors. Restoring XPO5 function shows tumor-suppressor activity by enabling pre-miRNA nuclear export.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Global impairment of mature microRNAs (miRNAs) is a hallmark of human cancers.
- Defects in precursor miRNA (pre-miRNA) nuclear export may occur in cancer cells.
Purpose of the Study:
- To investigate the role of Exportin 5 (XPO5) in human tumors.
- To identify genetic alterations in XPO5 and their functional consequences in cancer.
Main Methods:
- Screening for XPO5 mutations in human tumors with microsatellite instability.
- Assessing the impact of XPO5 mutations on pre-miRNA nuclear export and miRNA processing.
- Evaluating the tumor-suppressor potential of restored XPO5 function.
Main Results:
- XPO5-inactivating mutations were identified in a subset of human tumors exhibiting microsatellite instability.
- These mutations trap pre-miRNAs in the nucleus, hindering miRNA processing and target inhibition.
- The C-terminal region's absence in mutant XPO5 disrupts the pre-miRNA/XPO5/Ran-GTP complex formation.
- Restoration of XPO5 function normalized pre-miRNA export and demonstrated tumor-suppressive effects.
Conclusions:
- XPO5 mutations represent a novel mechanism contributing to miRNA dysregulation in cancer.
- XPO5 acts as a tumor suppressor by facilitating pre-miRNA nuclear export.
- Targeting XPO5 pathways may offer therapeutic strategies for specific human tumors.
Related Concept Videos
Nuclear Export
NES are of three types- the canonical 10-residue long leucine-rich signal and other...
MicroRNAs
MicroRNAs
MicroRNAs
Nuclear Export of mRNA
Nuclear Export of mRNA